European Breast Cancer Council manifesto 2018: Genetic risk prediction testing in breast cancer

Eur J Cancer. 2019 Jan:106:45-53. doi: 10.1016/j.ejca.2018.09.019. Epub 2018 Nov 22.

Abstract

European Breast Cancer Council manifesto and supporting article on genetic risk prediction testing in breast cancer, presented at the 11th European Breast Cancer Conference in Barcelona, Spain.

Keywords: BRCA1/BRCA2; Breast cancer; Direct-to-consumer tests; Genetic counselling; Genetic testing; Regulation.

Publication types

  • Practice Guideline

MeSH terms

  • BRCA1 Protein / genetics
  • BRCA2 Protein / genetics
  • Biomarkers, Tumor / genetics*
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy
  • Consensus
  • Direct-To-Consumer Screening and Testing*
  • Early Detection of Cancer*
  • Female
  • Genetic Counseling
  • Genetic Predisposition to Disease
  • Genetic Testing*
  • Heredity
  • Humans
  • Molecular Targeted Therapy
  • Mutation*
  • Pedigree
  • Phenotype
  • Precision Medicine
  • Predictive Value of Tests
  • Reproducibility of Results
  • Risk Assessment
  • Risk Factors

Substances

  • BRCA1 Protein
  • BRCA1 protein, human
  • BRCA2 Protein
  • BRCA2 protein, human
  • Biomarkers, Tumor